Find similar content

Source channel @githubtrending · Post #14862 · Jun 24

#typescript#codemirror#graphiql#graphql#lsp_mode#lsp_server#monaco_editor#vscode GraphiQL is a powerful, open-source GraphQL IDE that helps you write, test, and explore GraphQL queries easily in your browser or desktop. It offers features like syntax highlighting, live error checking, and schema exploration, making it simpler to work with GraphQL APIs. The project is part of a monorepo that includes tools for different editors like CodeMirror and Monaco, providing a consistent and extensible development experience. Using this monorepo setup improves collaboration, code sharing, and maintenance across related tools, saving you time and effort when building or extending GraphQL IDEs. This means you get a reliable, efficient environment to develop GraphQL applications faster and with fewer errors. https://github.com/graphql/graphiql

Hashtags

#typescript #codemirror #graphiql #graphql #lsp_mode #lsp_server #monaco_editor #vscode

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment